EQT CORP (EQT) Forecast, Price Target & Analyst Ratings
NYSE:EQT • US26884L1098
64.27 USD
-0.37 (-0.57%)
Last: Mar 13, 2026, 09:30 AM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EQT CORP (EQT).
Forecast Snapshot
Consensus Price Target
$65.82
+ 2.42% Upside
Next Earnings Forecast
Release DateApr 20, 2026
PeriodQ1 / 2026
EPS Estimate$1.88
Revenue Estimate3.191B
ChartMill Buy Consensus
80.63%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$65.82
Upside
+ 2.42%
From current price of $64.27 to mean target of $65.82, Based on 32 analyst forecasts
Low
$48.29
Median
$66.81
High
$79.80
Price Target Revisions
1 Month
1.04%
3 Months
0.19%
Price Target Summary
32 Wall Street analysts provided a forecast for the next 12 months for EQT. The average price target is 65.82 USD. This implies a price increase of 2.42% is expected in the next year compared to the current price of 64.27.
The average price target has been revised upward by 0.19% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.63%
EQT was analyzed by 32 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about EQT.
In the previous month the buy percentage consensus was at a similar level.
EQT was analyzed by 32 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-05 | UBS | Maintains | Buy -> Buy |
| 2026-03-05 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2026-02-23 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-20 | TD Cowen | Maintains | Buy -> Buy |
| 2026-02-18 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2026-01-22 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2026-01-21 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-05 | Bernstein | Maintains | Outperform -> Outperform |
| 2025-12-19 | Citigroup | Maintains | Buy -> Buy |
| 2025-12-12 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-12-12 | UBS | Maintains | Buy -> Buy |
| 2025-11-21 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2025-11-18 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-10-23 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-17 | UBS | Maintains | Buy -> Buy |
| 2025-10-15 | William Blair | Initiate | Outperform |
| 2025-10-09 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2025-10-07 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-10-07 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-02 | Jefferies | Maintains | Buy -> Buy |
| 2025-09-30 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-08-22 | B of A Securities | Maintains | Buy -> Buy |
| 2025-08-20 | Melius Research | Initiate | Buy |
| 2025-08-20 | UBS | Maintains | Buy -> Buy |
| 2025-08-18 | Roth Capital | Downgrade | Buy -> Neutral |
Next Earnings Forecast Details
Next Earnings Details
Release DateApr 20, 2026
PeriodQ1 / 2026
EPS Estimate$1.88
Revenue Estimate3.191B
Revenue Q2Q83.41%
EPS Q2Q59.19%
Number of Analysts24
Next Earnings Revisions
Revenue (1 Month)
23.59%
Revenue (3 Months)
18.76%
EPS (1 Month)
39.41%
EPS (3 Months)
32.49%
Next Earnings Summary
EQT is expected to report earnings on 4/20/2026. The consensus EPS estimate for the next earnings is 1.88 USD and the consensus revenue estimate is 3.19B USD.
The next earnings revenue estimate has been revised upward by 18.76% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.909B -7.85% | 5.273B -23.67% | 8.644B 63.92% | 9.912B 14.67% | 9.752B -1.61% | 9.951B 2.04% | 11.743B 18.01% | 12.308B 4.81% | 12.954B 5.25% | 13.425B 3.64% | 13.811B 2.88% | |
| EBITDA YoY % growth | 4.251B -11.87% | 2.507B -41.04% | 6.091B 142.99% | 6.983B 14.64% | 6.87B -1.62% | 6.608B -3.81% | 7.468B 13.01% | 7.857B 5.21% | 6.48B -17.53% | 6.75B 4.17% | 6.961B 3.13% | |
| EBIT YoY % growth | 2.519B -20.22% | 344.31M -86.33% | 3.491B 913.81% | 4.533B 29.86% | 4.416B -2.58% | 4.902B 11.01% | 3.07B -37.37% | 3.233B 5.31% | 3.653B 12.99% | 3.707B 1.48% | N/A | |
| Operating Margin | 36.46% | 6.53% | 40.38% | 45.73% | 45.28% | 49.26% | 26.14% | 26.27% | 28.20% | 27.61% | N/A | |
| EPS YoY % growth | 2.31 -25.48% | 1.55 -32.90% | 3.05 96.77% | 4.65 52.43% | 4.69 0.90% | 5.08 8.39% | 6.58 29.32% | 6.93 5.38% | 4.04 -41.69% | 4.04 | 4.04 |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.88 59.19% | 0.73 62.82% | 0.93 78.28% | 1.31 45.48% | 1.57 -16.52% | 1.27 73.63% | 1.35 46.14% | 1.54 17.88% |
| Revenue Q2Q % growth | 3.191B 83.41% | 2.136B -16.49% | 2.193B 11.97% | 2.594B 8.62% | 2.791B -12.54% | 2.398B 12.27% | 2.57B 17.19% | 2.755B 6.21% |
| EBITDA Q2Q % growth | 2.281B 103.68% | 1.387B -41.83% | 1.581B -37.60% | 1.879B -48.23% | 2.169B -4.91% | 1.685B 21.49% | 1.746B 10.44% | 1.941B 3.30% |
| EBIT Q2Q % growth | 1.827B 266.03% | 782.24M -31.40% | 930.66M 54.84% | 1.291B 25.45% | 1.443B -21.02% | 1.038B 32.70% | 1.166B 25.29% | 1.344B 4.11% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
18.57%
EPS Next 5 Year
17.83%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
5.79%
Revenue Next 5 Year
7.92%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
29.57%
EBIT Next 5 Year
20.93%
EQT CORP / EQT Forecast FAQ
What is the average price target for EQT CORP (EQT) stock?
32 analysts have analysed EQT and the average price target is 65.82 USD. This implies a price increase of 2.42% is expected in the next year compared to the current price of 64.27.
When does EQT CORP (EQT) report earnings?
EQT CORP (EQT) will report earnings on 2026-04-20, after the market close.
What are the consensus estimates for EQT CORP (EQT) next earnings?
The consensus EPS estimate for the next earnings of EQT CORP (EQT) is 1.88 USD and the consensus revenue estimate is 3.19B USD.
What is the consensus rating for EQT CORP (EQT) stock?
The consensus rating for EQT CORP (EQT) is 80.625 / 100 . This indicates that analysts generally have a positive outlook on the stock.